Jonathan R. Brody, Ph.D.
Affiliations: | 2003 | Johns Hopkins University, Baltimore, MD |
Area:
Pathology, Molecular Biology, OncologyGoogle:
"Jonathan Brody"Mean distance: (not calculated yet)
Parents
Sign in to add mentorGary Roy Pasternack | grad student | 2003 | Johns Hopkins | |
(* pp32 (ANP32A) in differentiation and cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shah VM, Rizvi S, Smith A, et al. (2023) Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment. Pharmaceutics. 15 |
Finan JM, Sutton TL, Dixon DA, et al. (2023) Targeting the RNA-binding protein HuR in cancer. Cancer Research |
McCarthy GA, Di Niro R, Finan JM, et al. (2023) Deletion of the mRNA stability factor (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity. Nar Cancer. 5: zcad016 |
Korzun T, Moses AS, Kim J, et al. (2022) Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small (Weinheim An Der Bergstrasse, Germany). e2204436 |
Vaziri-Gohar A, Cassel J, Mohammed FS, et al. (2022) Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors. Nature Cancer |
Shupp AB, Neupane M, Agostini LC, et al. (2021) Stromal-derived extracellular vesicles suppress proliferation of bone metastatic cancer cells mediated by ERK2. Molecular Cancer Research : McR |
Pishvaian MJ, Wang H, He AR, et al. (2020) A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Lowder CY, Dhir T, Goetz AB, et al. (2020) A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience. Surgical Oncology. 33: 118-125 |
Pishvaian MJ, Blais EM, Brody JR, et al. (2020) Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. The Lancet. Oncology |
Nevler A, Brown SZ, Nauheim D, et al. (2020) Effect of Hypercapnia, an Element of Obstructive Respiratory Disorders, on Pancreatic Cancer Chemoresistance and Progression. Journal of the American College of Surgeons |